Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.
Voxel S.A. (VOX) - Net Assets
Latest net assets as of September 2025: zł390.08 Million PLN
Based on the latest financial reports, Voxel S.A. (VOX) has net assets worth zł390.08 Million PLN as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł676.24 Million) and total liabilities (zł286.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł390.08 Million |
| % of Total Assets | 57.68% |
| Annual Growth Rate | 12.29% |
| 5-Year Change | 102.37% |
| 10-Year Change | 229.86% |
| Growth Volatility | 10.2 |
Voxel S.A. - Net Assets Trend (2010–2024)
This chart illustrates how Voxel S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Voxel S.A. (2010–2024)
The table below shows the annual net assets of Voxel S.A. from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł366.64 Million | +24.11% |
| 2023-12-31 | zł295.41 Million | +21.11% |
| 2022-12-31 | zł243.91 Million | +5.81% |
| 2021-12-31 | zł230.53 Million | +27.24% |
| 2020-12-31 | zł181.17 Million | +16.31% |
| 2019-12-31 | zł155.77 Million | +8.74% |
| 2018-12-31 | zł143.25 Million | +9.81% |
| 2017-12-31 | zł130.46 Million | +12.10% |
| 2016-12-31 | zł116.38 Million | +4.71% |
| 2015-12-31 | zł111.15 Million | +7.43% |
| 2014-12-31 | zł103.47 Million | -4.98% |
| 2013-12-31 | zł108.89 Million | +31.76% |
| 2012-12-31 | zł82.64 Million | -0.89% |
| 2011-12-31 | zł83.39 Million | +15.24% |
| 2010-12-31 | zł72.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Voxel S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 26158367505.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł261.21 Million | 72.44% |
| Common Stock | zł10.50 Million | 2.91% |
| Other Components | zł88.86 Million | 24.64% |
| Total Equity | zł360.57 Million | 100.00% |
Voxel S.A. Competitors by Market Cap
The table below lists competitors of Voxel S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
$144.21 Million |
|
Biodyne Co. Ltd.
KQ:314930
|
$144.24 Million |
|
Chien Kuo Construction Co Ltd
TW:5515
|
$144.26 Million |
|
Vuzix Corp Cmn Stk
NASDAQ:VUZI
|
$144.28 Million |
|
Ganesha Ecosphere Limited
NSE:GANECOS
|
$144.18 Million |
|
Tracsis plc
PINK:TCIIF
|
$144.17 Million |
|
Isabella Bank Corporation
OTCQX:ISBA
|
$144.13 Million |
|
Galectin Therapeutics Inc
NASDAQ:GALT
|
$144.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Voxel S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 293,313,800 to 360,569,200, a change of 67,255,400 (22.9%).
- Net income of 96,452,600 contributed positively to equity growth.
- Dividend payments of 34,574,000 reduced retained earnings.
- Other factors increased equity by 5,376,800.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł96.45 Million | +26.75% |
| Dividends Paid | zł34.57 Million | -9.59% |
| Other Changes | zł5.38 Million | +1.49% |
| Total Change | zł- | 22.93% |
Book Value vs Market Value Analysis
This analysis compares Voxel S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.98x to 3.47x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | zł7.96 | zł119.20 | x |
| 2011-12-31 | zł9.32 | zł119.20 | x |
| 2012-12-31 | zł8.34 | zł119.20 | x |
| 2013-12-31 | zł10.37 | zł119.20 | x |
| 2014-12-31 | zł9.85 | zł119.20 | x |
| 2015-12-31 | zł10.57 | zł119.20 | x |
| 2016-12-31 | zł11.07 | zł119.20 | x |
| 2017-12-31 | zł12.41 | zł119.20 | x |
| 2018-12-31 | zł13.63 | zł119.20 | x |
| 2019-12-31 | zł14.83 | zł119.20 | x |
| 2020-12-31 | zł17.12 | zł119.20 | x |
| 2021-12-31 | zł21.80 | zł119.20 | x |
| 2022-12-31 | zł23.03 | zł119.20 | x |
| 2023-12-31 | zł27.93 | zł119.20 | x |
| 2024-12-31 | zł34.33 | zł119.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Voxel S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.75%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.00%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.77x
- Recent ROE (26.75%) is above the historical average (12.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 3.58% | 4.19% | 0.36x | 2.39x | zł-4.62 Million |
| 2011 | -4.62% | -3.94% | 0.48x | 2.45x | zł-12.13 Million |
| 2012 | 3.88% | 5.55% | 0.34x | 2.03x | zł-5.06 Million |
| 2013 | 2.79% | 2.92% | 0.48x | 1.99x | zł-7.81 Million |
| 2014 | -3.31% | -3.33% | 0.48x | 2.08x | zł-13.77 Million |
| 2015 | 12.91% | 10.86% | 0.62x | 1.91x | zł3.23 Million |
| 2016 | 9.46% | 9.12% | 0.54x | 1.92x | zł-623.73K |
| 2017 | 15.20% | 13.01% | 0.64x | 1.83x | zł6.77 Million |
| 2018 | 16.33% | 13.72% | 0.60x | 1.97x | zł9.06 Million |
| 2019 | 14.75% | 10.85% | 0.63x | 2.17x | zł7.40 Million |
| 2020 | 18.88% | 10.37% | 0.75x | 2.44x | zł15.98 Million |
| 2021 | 30.81% | 15.94% | 0.89x | 2.16x | zł47.65 Million |
| 2022 | 18.37% | 10.71% | 0.89x | 1.93x | zł20.24 Million |
| 2023 | 25.30% | 17.49% | 0.80x | 1.80x | zł44.87 Million |
| 2024 | 26.75% | 19.00% | 0.79x | 1.77x | zł60.40 Million |
Industry Comparison
This section compares Voxel S.A.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $30,669,658
- Average return on equity (ROE) among peers: 9.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Voxel S.A. (VOX) | zł390.08 Million | 3.58% | 0.73x | $144.21 Million |
| Biomaxima (BMX) | $25.94 Million | 30.64% | 1.06x | $7.70 Million |
| Scope Fluidics SA (SCP) | $16.88 Million | -24.72% | 0.11x | $52.93 Million |
| Selvita S.A. (SLV) | $49.19 Million | 21.34% | 0.48x | $129.09 Million |